Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy - Wikidata - awgldk - TriplyDB

Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy

Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy

http://www.wikidata.org/entity/Q28475894

about

PI3K/AKT/mTOR Pathway in Angiogenesis Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells.The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy.Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models Human bone marrow stromal cells display variable anatomic site-dependent response and recovery from irradiation Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity.Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signaling pathways.Intra-Laboratory Pre-Validation of a Human Cell Based in vitro Angiogenesis Assay for Testing Angiogenesis Modulators.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck.Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia.The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms.The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation.Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy.Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients.Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B.Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

P2860

Q21129332-48769DD4-2BA2-4B3A-9577-2FDA4016FFE0 Q26828930-A22C0167-6B32-409A-88B3-F7C3C509C6E1 Q27025579-4A92091B-B813-4586-B383-BCFA747055FF Q28085180-F714C7D3-58AC-4494-9527-F45DA3A39663 Q28574797-00B623EC-2051-41F2-A2C4-1527215FF324 Q28710339-4A903DC6-78C3-42CA-8D82-8C70A68C4701 Q30469815-812C61AA-7BB9-4447-B8F1-C1A24F0443FA Q30471456-CC723ED4-F60E-4853-AD56-A1E7455F7BC3 Q30539057-72BAFF41-DFB1-4F00-B2AF-556D16DF1C3D Q33705268-B6DE1681-9F25-4E13-B8B7-D458FA126EFF Q33733303-CC20DB19-C258-4764-98DE-B52C5B505B4D Q33879424-F4378747-43B8-4B32-80FC-A9AE73573CA7 Q33917246-A1987C41-CB69-423D-9D24-477296F2B692 Q33920350-8ACE78F3-D05E-4148-8987-FF917512C4F9 Q34081980-F356704B-9103-4FCC-8878-C58176F631FE Q34105339-FFAD087A-07BF-46A2-81EB-304DDC5A51B6 Q34230220-FF92FDEB-747C-4622-8B22-E77F675B9F3D Q34563668-82DCA4EE-C161-48D2-9442-E34CB55DDAE9 Q34762840-3A792565-1BF6-46FC-A141-53E420BB4A7B Q34782683-DE970069-9B20-4980-A008-96807764EDD9 Q34848038-F17BE338-6D23-43DB-95E4-82F66F865A10 Q35017125-8E7582C9-FDDD-4400-BF7F-7B3DDE7D6D3F Q35100891-846489D1-5C07-4419-AA1A-CA807F84B905 Q35165488-19CC3387-1C7E-4380-9AFF-144F8951D3DA Q35172674-3C39965F-7BEC-43A1-B105-C1F36A111217 Q35184804-6D13247C-251E-450E-ADD4-FF4DDA180A9C Q35382105-497F8B1C-D968-49FF-A3FD-F0EA093ED5F3 Q35649008-C1DF21F3-AFBE-484E-A798-9F3278F739BE Q35766780-CDC63A1E-BAF7-4C58-864E-FAF0932163EC Q35836433-D78285D3-4E00-484E-8707-00C42371E49E Q35920966-78F76EB9-E7E3-49C8-AFB4-108167DF20D8 Q35930433-40450F52-0484-4D6A-925C-B42AC6A8D5FB Q36048159-8BEC818A-A121-4174-AB81-FB9CBA21DC52 Q36068704-85618CBF-3ACD-49FD-A3AF-83017E37A674 Q36074410-0FCCF25B-AB56-48BC-A4EB-472B8BDAE8E6 Q36229899-B1D35652-217D-47B9-8799-82D1ED695A4B Q36360133-4A0CFC01-1E6B-4D5F-8D61-BD0DA695F691 Q37088535-2BB1D385-D89B-4605-B2A9-5345FD39194B Q37174984-C6624266-1FED-4537-91A2-7C15EE4444C7 Q37364878-B5EAD998-E3EB-4F2A-A259-66F83476C073

P2860

Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy

http://www.wikidata.org/entity/Q28475894

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@ast

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@en

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@nl

type

label

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@ast

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@en

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@nl

prefLabel

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@ast

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@en

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@nl

P1433

Q28475894-D6F55400-5B7F-4EAB-A6C6-8EA2150A1FF8

P1476

Q28475894-A337BE8A-293C-4C73-AC3F-36C35FD03966

P2093

Q28475894-01D3A3F9-F783-4D19-AD2D-A2FF2ECFFA67

Q28475894-13D32E29-3608-411A-8513-33121D675150

Q28475894-4154882D-D8A3-4836-8ACE-95835E6C16DA

Q28475894-435A022C-B3D1-4EB9-BF1E-7D3B8AE08C65

Q28475894-4EAE434B-BA12-495B-ADB9-CD21E66C268B

Q28475894-5759832D-A585-4742-BF99-F2F8A8EBECA0

Q28475894-5E1E9FE8-2633-407B-BE77-141242E2A80A

Q28475894-635A36C7-7613-4402-8C2D-2BEB5AF04AB5

Q28475894-6E3A9E49-7575-42AB-A3AD-3DDC86C8BD5F

Q28475894-85DF545C-F480-4CE0-9A56-BAC6FBB1692C

P2860

Q28475894-008CB859-CC50-44FE-B8AF-49014F52EF3F

Q28475894-03A50A23-7110-4B77-8425-4CD5F212F405

Q28475894-066534EF-011A-443A-8E36-44C324AF65D1

Q28475894-091A7463-1BF0-4241-8382-B81F97B0A80B

Q28475894-26C52756-C328-4A22-BA31-B5490EFE04D9

Q28475894-2C4FC890-B352-4283-A56A-6C558637C073

Q28475894-2DC226E9-6A2E-47DD-A986-BE5D64EC308F

Q28475894-342822A9-D9A3-4DC0-899C-CD1D62810911

Q28475894-3A2DF6CC-4C1C-42D5-9F3A-E9F1A4930C53

Q28475894-3FE8EC7B-96FA-43B8-A311-A5649B8AD4F4

P304

Q28475894-D4C5429D-578C-45C1-AD01-22F01A8545BC

P31

Q28475894-960DF842-BDBA-4420-9A2A-6FD92AF0C52D

P356

Q28475894-7D5B05C4-3009-43D7-B0A0-1BAB1268D7D7

P407

Q28475894-CFB75F70-840B-455F-BCB9-C4889A40F10F

P433

Q28475894-7BFAD6A2-2056-4CDD-9A45-C1CE07A5ED18

P478

Q28475894-15582D6C-EBC4-4EB1-9A87-AF72B3AFFEF7

P50

Q28475894-B71551E0-B491-45B3-A6FA-E3132374D1B3

Q28475894-DAD8A082-F505-4925-80C6-5824BC085DBB

P577

Q28475894-6B0C6BEB-4646-40D6-928D-6D3B86C8AD8C

P5875

Q28475894-92112AA2-CA1C-4213-AF12-3309F2E80486

P698

Q28475894-8DF8297C-A243-4F16-ABE8-BC026EBBCE1E

P921

Q28475894-109EABD7-D708-4FDE-ACE0-8484205DF637

Q28475894-E77DA78A-C2A5-4AEB-A93E-5B8913B0BC47

P932

Q28475894-32C5AF62-5AA0-4091-8BF6-506C44E79D48

P356

JOURNAL.PONE.0006539

P1433

P1476

Epidermal growth factor recept ...... rapy and radiotherapy efficacy

@en

P2093

Amit Maity

http://www.w3.org/2001/XMLSchema#string

Arjun G Yodh

http://www.w3.org/2001/XMLSchema#string

Cameron J Koch

http://www.w3.org/2001/XMLSchema#string

Chandra M Sehgal

http://www.w3.org/2001/XMLSchema#string

George J Cerniglia

http://www.w3.org/2001/XMLSchema#string

Harry Quon

http://www.w3.org/2001/XMLSchema#string

Jeff H Tsai

http://www.w3.org/2001/XMLSchema#string

Nabendu Pore

http://www.w3.org/2001/XMLSchema#string

Rosemarie Mick

http://www.w3.org/2001/XMLSchema#string

Stephen M Hahn

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Tumor angiogenesis: therapeutic implications

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Loss of PTEN facilitates HIF-1-mediated gene expression

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

P304

e6539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0006539

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Sydney M. Evans

P577

2009-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26719546

http://www.w3.org/2001/XMLSchema#string

P698

19657384

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2716529

http://www.w3.org/2001/XMLSchema#string